BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36281785)

  • 1. Aminoglycoside-induced lipotoxicity and its reversal in kidney on chip.
    Ioannidis K; Cohen A; Ghosheh M; Ehrlich A; Fischer A; Cohen M; Nahmias Y
    Lab Chip; 2022 Nov; 22(23):4469-4480. PubMed ID: 36281785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium-glucose transporter-2 (SGLT2; SLC5A2) enhances cellular uptake of aminoglycosides.
    Jiang M; Wang Q; Karasawa T; Koo JW; Li H; Steyger PS
    PLoS One; 2014; 9(9):e108941. PubMed ID: 25268124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism and reversal of drug-induced nephrotoxicity on a chip.
    Cohen A; Ioannidis K; Ehrlich A; Regenbaum S; Cohen M; Ayyash M; Tikva SS; Nahmias Y
    Sci Transl Med; 2021 Feb; 13(582):. PubMed ID: 33627489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gentamicin, netilmicin, dibekacin, and amikacin nephrotoxicity and its relationship to tubular reabsorption in rabbits.
    Brion N; Barge J; Godefroy I; Dromer F; Dubois C; Contrepois A; Carbon C
    Antimicrob Agents Chemother; 1984 Feb; 25(2):168-72. PubMed ID: 6712201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity.
    Nagai J; Takano M
    Drug Metab Pharmacokinet; 2004 Jun; 19(3):159-70. PubMed ID: 15499183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted prevention of renal accumulation and toxicity of gentamicin by aminoglycoside binding receptor antagonists.
    Watanabe A; Nagai J; Adachi Y; Katsube T; Kitahara Y; Murakami T; Takano M
    J Control Release; 2004 Mar; 95(3):423-33. PubMed ID: 15023454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choice of drug and dosage regimen. Two important risk factors for aminoglycoside nephrotoxicity.
    De Broe ME; Giuliano RA; Verpooten GA
    Am J Med; 1986 Jun; 80(6B):115-8. PubMed ID: 3728523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoglycoside-induced functional and biochemical defects in the renal cortex.
    Kaloyanides GJ
    Fundam Appl Toxicol; 1984 Dec; 4(6):930-43. PubMed ID: 6519373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of aminoglycoside antibiotics on chicken cystatin binding to renal brush-border membranes.
    Konopska B; Gburek J; Gołąb K; Warwas M
    J Pharm Pharmacol; 2013 Jul; 65(7):988-94. PubMed ID: 23738726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CLIMP-63 is a gentamicin-binding protein that is involved in drug-induced cytotoxicity.
    Karasawa T; Wang Q; David LL; Steyger PS
    Cell Death Dis; 2010 Nov; 1(11):e102. PubMed ID: 21368867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminoglycoside antibiotics alter the electrogenic transport properties of cultured human proximal tubule cells.
    Todd JH; Sens DA; Hazen-Martin DJ; Bylander JE; Smyth BJ; Sens MA
    Toxicol Pathol; 1992; 20(4):608-16. PubMed ID: 1339217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoglycoside nephrotoxicity: pathogenesis and prevention.
    Cronin RE
    Clin Nephrol; 1979 May; 11(5):251-6. PubMed ID: 378495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglycoside nephrotoxicity: comparative assessment in critically ill patients.
    Plaut ME; Schentag JJ; Jusko WJ
    J Med; 1979; 10(4):257-66. PubMed ID: 294466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth characteristics of cultured human proximal tubule cells exposed to aminoglycoside antibiotics.
    Sens MA; Hazen-Martin DJ; Blackburn JG; Hennigar GR; Sens DA
    Ann Clin Lab Sci; 1989; 19(4):266-79. PubMed ID: 2757354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased renal accumulation of aminoglycoside reflects defective receptor-mediated endocytosis in cystic fibrosis and Dent's disease.
    Raggi C; Fujiwara K; Leal T; Jouret F; Devuyst O; Terryn S
    Pflugers Arch; 2011 Dec; 462(6):851-60. PubMed ID: 21927812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between the nephrotoxic profile of gentamicin and gentamicin nanoparticles in mice.
    Jamshidzadeh A; Heidari R; Mohammadi-Samani S; Azarpira N; Najbi A; Jahani P; Abdoli N
    J Biochem Mol Toxicol; 2015 Feb; 29(2):57-62. PubMed ID: 25293820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminoglycoside antibiotics reduce glucose reabsorption in kidney through down-regulation of SGLT1.
    Takamoto K; Kawada M; Usui T; Ishizuka M; Ikeda D
    Biochem Biophys Res Commun; 2003 Sep; 308(4):866-71. PubMed ID: 12927799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Megalin deficiency offers protection from renal aminoglycoside accumulation.
    Schmitz C; Hilpert J; Jacobsen C; Boensch C; Christensen EI; Luft FC; Willnow TE
    J Biol Chem; 2002 Jan; 277(1):618-22. PubMed ID: 11700326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoglycoside renal cortical kinetics: a clue to mechanisms of nephrotoxicity.
    Whelton A
    Prog Clin Biol Res; 1979; 35():33-41. PubMed ID: 395539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative nephrotoxicity of dibekacin and gentamicin in rats.
    Elliott WC; Parker RA; Houghton DC; Gilbert DN; Bennett WM
    Res Commun Chem Pathol Pharmacol; 1981 Sep; 33(3):419-32. PubMed ID: 7330450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.